價(jià)格 | ¥245 | ¥355 | ¥498 |
包裝 | 25mg | 50mg | 100mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-14 |
中文名稱(chēng):哌拉西林鈉 | 英文名稱(chēng):Piperacillin sodium |
CAS:59703-84-3 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.66% | 產(chǎn)品類(lèi)別: 抑制劑 |
貨號(hào): T1213 |
名稱(chēng) | Piperacillin sodium |
描述 | (CL227193) )binds to and inactivates penicillin-binding proteins (PBPs), enzymes located on the inner membrane of the bacterial cell wall, resulting in the weakening of the bacterial cell wall and cell lysis. Piperacillin Sodium is the sodium salt of piperacillin, a broad-spectrum semisynthetic, ampicillin-derived ureidopenicillin antibiotic with bactericidal activity. PBPs participate in the terminal stages of assembling the bacterial cell wall, and in reshaping the cell wall during cell division. Inactivation of PBPs interferes with the cross-linkage of peptidoglycan chains necessary for bacterial cell wall strength and rigidity. |
激酶實(shí)驗(yàn) | Inhibition of Prostaglandin Formation: Recombinant COX-1 and COX-2 from rat (rCOX) and human (hCOX) expressed in a baculovirus system are purified and reconstituted with 2 mM phenol and 1 μM hematin. Then the cyclooxygenase activity is measured using a radiometric assay, and the specific activity of the final enzyme preparations used is between 20,000 and 35,000 units. Ketorolac (2 -15 μL) are diluted in DMSO and preincubated with the appropriate recombinant COX (3 -15 ng) at a final concentration of 0.01 to 1000 μM in a reaction mixture (150 μL) containing 50 mM Tris-HCl buffer (pH 7.9), 2 mM EDTA, 10% glycerol, 2 mM phenol, and 1 μM hematin for 10 minutes. The reaction is initiated by addition of [14C]arachidonic acid (50–60 mCi/mmol in a final concentration of 20 μM) and is terminated 45 seconds later by the addition of 100 μL of 0.2 N HCl and 750 μL of distilled water. The total reaction volume is then applied to a 1 mL C18 Sep-pak column that has previously been washed with 2 mL of methanol followed by 5 mL of deionized water. Oxygenated products are eluted with 3 mL of a mixture of acetonitrile/water/acetic acid (50:50:0.1, v/v/v) and quantified by liquid scintillation spectroscopy. |
體內(nèi)活性 | Piperacillin對(duì)陽(yáng)性/陰性革蘭氏和需氧/厭氧細(xì)菌具有體外抗菌活性。Piperacillin通過(guò)與青霉素結(jié)合蛋白結(jié)合進(jìn)行調(diào)節(jié)抑制細(xì)菌細(xì)胞壁合成。各種β-內(nèi)酰胺酶,包括頭孢菌素酶、青霉素酶以及廣譜β-內(nèi)酰胺酶均無(wú)法使Piperacillin水解。 |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | H2O : 92 mg/mL (170.5 mM) Ethanol : 93 mg/mL (172.4 mM) DMSO : 93 mg/mL (172.4 mM) |
關(guān)鍵字 | Piperacillin sodium | Piperacillin | Inhibitor | inhibit | CL-227193 | CL 227193 | Bacterial | Antibiotic |
相關(guān)產(chǎn)品 | Crystal Violet | Dehydroacetic acid sodium | G-418 disulfate | Doxycycline | Methyl anthranilate | Neomycin sulfate | Metronidazole | Dimethyl sulfoxide | EDTA copper(II) disodium salt | Ampicillin sodium | Sulfamethoxazole sodium | Kanamycin sulfate |
相關(guān)庫(kù) | 經(jīng)典已知活性庫(kù) | 已知活性化合物庫(kù) | 抗菌活性庫(kù) | 抗感染化合物庫(kù) | FDA上市及藥典收錄分子庫(kù) | 上市藥物庫(kù) | NO PAINS 化合物庫(kù) | 抗COVID-19化合物庫(kù) | FDA 上市藥物庫(kù) | 免疫/炎癥分子化合物庫(kù) | 藥物功能重定位化合物庫(kù) | 兒童藥物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.2651萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 化學(xué)試劑,生物活性小分子 | 經(jīng)營(yíng)模式 | 貿(mào)易,試劑,定制,服務(wù) |
產(chǎn)品名稱(chēng) | 價(jià)格 | 公司名稱(chēng) | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢(xún)價(jià) |
VIP5年
|
武漢克米克生物醫(yī)藥技術(shù)有限公司
|
2024-11-16 | |
¥1200 |
VIP12年
|
湖北威德利化學(xué)科技有限公司
|
2024-11-15 | |
詢(xún)價(jià) |
VIP6年
|
湖北威德利化學(xué)試劑有限公司
|
2024-11-15 | |
詢(xún)價(jià) |
VIP4年
|
武漢東康源科技有限公司
|
2024-11-15 | |
¥549 |
VIP4年
|
湖北魏氏化學(xué)試劑股份有限公司
|
2024-11-15 | |
詢(xún)價(jià) |
VIP4年
|
江西瑞威爾生物科技有限公司
|
2024-11-15 | |
¥350 |
VIP9年
|
武漢維斯?fàn)柭锕こ逃邢薰?/div>
|
2024-11-15 | |
¥123 |
VIP5年
|
武漢鼎信通藥業(yè)有限公司
|
2024-11-15 | |
詢(xún)價(jià) |
VIP5年
|
武漢鼎信通藥業(yè)有限公司
|
2024-11-15 | |
詢(xún)價(jià) |
VIP5年
|
武漢鼎信通藥業(yè)有限公司
|
2024-11-15 |